Write in a clean editor, then format for The World Journal of Biological Psychiatry in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
The World Journal of Biological Psychiatry is a peer-reviewed journal published by Taylor & Francis, covering Schizophrenia research and treatment, Tryptophan and brain disorders, Bipolar Disorder and Treatment.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." The World Journal of Biological Psychiatry 12 (3): 45–58.
Formats any DOI in The World Journal of Biological Psychiatry style. No sign-up. |
| Publishes research in | Schizophrenia research and treatment Tryptophan and brain disorders Bipolar Disorder and Treatment Treatment of Major Depression Neurotransmitter Receptor Influence on Behavior |
| ISSN | 1562-2975 |
| Citation impact (2-yr) | 3.11 |
| h-index | 110 |
| i10-index | 1,124 |
| Total citations | 58,685 |
| Top institutions publishing here | Ludwig-Maximilians-Universität München |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the pharmacological treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new…
These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaining to the biological treatment of schizophrenia were reviewed systematically to allow for an evidence-based update. These guidelines provide evidence-based practice…
OBJECTIVES: This 2013 update of the practice guidelines for the biological treatment of unipolar depressive disorders was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal has been to systematically review all available evidence pertaining to the treatment of unipolar depressive disorders, and to produce a…
These practical guidelines for the biological treatment of unipolar depressive disorders in primary care settings were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). They embody the results of a systematic review of all available clinical and scientific evidence pertaining to the treatment of unipolar depressive disorders…
OBJECTIVES: Alterations of BDNF signalling in major depression (MD) are supported by studies demonstrating decreased levels of the neurotrophin serum and plasma content in MD patients. We conducted a replication study and we performed two meta-analyses on studies analysing serum and plasma BDNF levels in MD patients. METHODS: The samples were composed by 489 patients/483…
